These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7173020)

  • 1. [Studies of HLA of the nasopharyngeal carcinoma epithelioid cell line and lymphoblastoid cell lines].
    Cui HY
    Zhonghua Zhong Liu Za Zhi; 1982 Aug; 4(3):168-70. PubMed ID: 7173020
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cell-mediated immunity and its HLA restriction in nasopharyngeal cancer patients].
    Lin YC
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):254-6. PubMed ID: 7166104
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between nasopharyngeal carcinoma and HLA antigens in Greeks.
    Zervas J; Gregoriadis S; Tourlas D; Varlegidis E; Pantazopoulos P
    Panminerva Med; 1983; 25(4):255-7. PubMed ID: 6584851
    [No Abstract]   [Full Text] [Related]  

  • 4. [HLA-A, B, C, DR antigens in north Chinese with nasopharyngeal carcinoma].
    Chen R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(2):106-7. PubMed ID: 3153944
    [No Abstract]   [Full Text] [Related]  

  • 5. [Apparent correlation between nasopharyngeal carcinoma and HLA phenotype].
    Cui HY
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):249-53. PubMed ID: 7166103
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological studies of HL-A on continuous lymphoblastoid cell lines (CLC) and the definition of an antigen on CLC determined by a heat-labile antibody.
    Dumble L; Jack I; Morris PJ
    Clin Exp Immunol; 1974 Jul; 17(3):441-54. PubMed ID: 4466611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of HLA monitoring in carcinoma of the nasopharynx].
    Síbl O; Ivasková E; Roubalová K
    Cesk Otolaryngol; 1987 Jul; 36(4):217-23. PubMed ID: 3664697
    [No Abstract]   [Full Text] [Related]  

  • 8. [HLA antigen typing in cells of human cell lines--some experience (author's transl)].
    Korínková P; Májský A
    Cas Lek Cesk; 1982 Feb; 121(5):150-1. PubMed ID: 7060070
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined transfection with EBV-specific epitopes and HLA-A2 genes is more effective than separate transfection in promoting CTL lysis against nasopharyngeal carcinoma.
    Ding W; Fong C
    Cell Mol Immunol; 2004 Jun; 1(3):229-34. PubMed ID: 16219173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distribution pattern of histocompatibility antigens (HLA) in nasopharyngeal tumors].
    Beigel A; Peulen JF; Westphal E
    Arch Otorhinolaryngol; 1983 Apr; 237(3):285-8. PubMed ID: 6870662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasopharyngeal carcinoma membrane soluble antigen.
    Tsukuda M; Sawaki S; Yanoma S; Yoshimura N; Takei M; Takada M; Sudo K; Suzuki K; Kawamura A
    Jpn J Exp Med; 1980 Feb; 50(1):79-84. PubMed ID: 6155484
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.
    Whitney BM; Chan AT; Rickinson AB; Lee SP; Lin CK; Johnson PJ
    J Med Virol; 2002 Jul; 67(3):359-63. PubMed ID: 12116028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA and nasopharyngeal cancer.
    Simons MJ; Chan SH; Day NE; Wee GB; Shanmugaratnam K
    Prog Clin Biol Res; 1977; 16():145-8. PubMed ID: 905319
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered HLA antibody absorption capacity of lymphoblastoid cells persistently infected with measles virus.
    Hsia S; Word MA; Ju G; Amos DB
    J Reticuloendothel Soc; 1981 Oct; 30(4):291-300. PubMed ID: 7031240
    [No Abstract]   [Full Text] [Related]  

  • 15. [The expression of HLA, Epstein-Barr virus nuclear antigen and the infiltration of T lymphocyte subsets in nasopharyngeal biopsy tissues].
    Chen X; Cai Y; Sun N
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(1):6-9. PubMed ID: 8031607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of lymphoblastoid cell lines for HLA-D-locus typing. III. Persistently weak responders.
    Gatti RA; Leibold W
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):111-4. PubMed ID: 854959
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted.
    Poláková K; Russ G
    Neoplasma; 2000; 47(6):342-8. PubMed ID: 11263857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of CD25+ lymphocytes in nasopharyngeal carcinoma and its association with EBV infection].
    Liu W; Han HX
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):94-7. PubMed ID: 16495186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of seven newly established nasopharyngeal carcinoma cell lines.
    Lin CT; Chan WY; Chen W; Huang HM; Wu HC; Hsu MM; Chuang SM; Wang CC
    Lab Invest; 1993 Jun; 68(6):716-27. PubMed ID: 7685844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E polymorphism in patients with nasopharyngeal carcinoma.
    Hirankarn N; Kimkong I; Mutirangura A
    Tissue Antigens; 2004 Nov; 64(5):588-92. PubMed ID: 15496202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.